Review: Fluid biomarkers for frontotemporal dementias
Year: 2018
Type: review
DOI: 10.1111/nan.12530
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Bristol-Myers Squibb, Eli Lilly and Company, University of California, National Institute on Handicapped Research, Wellcome Trust, Brain Research Trust, Wolfson Foundation, Alzheimer’s Research UK, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Knut och Alice Wallenbergs Stiftelse, Vetenskapsrådet, Alzheimer Nederland, National Institutes of Health, Genentech, Medical Research Council, National Institute on Aging, National Institute of Neurological Disorders and Stroke, H2020 European Research Council
Awards: G3903280126, The UK GENetic Frontotemporal dementia Initiative (UK GENFI), G7394515236, The Frontotemporal Lobar Degeneration Clinical Research Consortium, The Four Repeat Tauopathy Neuroimaging Initiative, G8611860269, Developing an evidence base for trials in genetic frontotemporal dementia - measures of disease onset and progression
OpenAlex ID: W2901302121
